Abstract 17b-Estradiol (E 2 ) binds estrogen receptor a (ESR1) in MCF-7 cells and increases cell proliferation and survival through induction or repression of multiple genes. ESR1 interactions with DNA-bound specificity protein (SP) transcription factors is a nonclassical genomic estrogenic pathway and the role of SP transcription factors in mediating hormone-dependent activation or repression of genes in MCF-7 cells was investigated by microarrays and RNA interference. MCF-7 cells were transfected with a nonspecific oligonucleotide or a cocktail of small inhibitory RNAs (iSP), which knockdown SP1, SP3, and SP4 proteins, and treated with dimethylsulfoxide or 10 nM E 2 for 6 h. E 2 induced 62 and repressed 134 genes and the induction or repression was reversed in w62% of the genes in cells transfected with iSP (ESR1/SP dependent), whereas hormonal activation or repression of the remaining genes was unaffected by iSP (SP independent). Analysis of the ESR1/SP-dependent and SP-independent genes showed minimal overlap with respect to the GO terms (functional processes) in genes induced or repressed, suggesting that the different genomic pathways may contribute independently to the hormone-induced phenotype in MCF-7 cells.
Introduction
The estrogen receptor (ER) and other steroid hormone receptors are members of the nuclear receptor (NR) superfamily of transcription factors that are characterized by their common modular structure and similar ligand-dependent mechanisms of action. NRs express an N-terminal A/B domain that contains a ligandindependent activation function-1, a DNA-binding domain C, a flexible hinge region (D), and a C-terminal E/F domain that contains a ligand-dependent AF-2 and a region that binds ligands (Katzenellenbogen et al. 1996 , Hall et al. 2001 , Nilsson & Gustafsson 2002 , Evans 2005 , O'Malley 2005 .
ESR1 and ESR2 are the two ER subtypes that exhibit overlapping and different patterns of expression in various tissues, and there is extensive evidence from in vitro cell culture, gene ablation, and in vivo studies that these receptors primarily have different functions (Matthews & Gustafsson 2003) . ESR1 was the first ER subtype identified and its role is associated with many of the familiar estrogen-mediated functions including female reproductive tract development, bone growth, and overexpression in early stage mammary tumors in women and in ER-positive (ER C ) breast cancer cells such as the widely used MCF-7 cell line (Levenson & Jordan 1997) . MCF-7 and other ER C breast cancer cell lines are highly responsive to the mitogenic activity of 17b-estradiol (E 2 ) and have been extensively used to understand the complex molecular biology of estrogen action. The classical mechanism of E 2 -induced gene expression involves ligand-dependent formation of a nuclear ER homodimer bound to an estrogen-responsive element (ERE) that in turn recruits multiple elements of the transcriptional machinery to activate gene expression (Katzenellenbogen et al. 1996 , Hall et al. 2001 , Nilsson & Gustafsson 2002 , Matthews & Gustafsson 2003 , Evans 2005 , O'Malley 2005 . Subsequent studies have identified multiple pathways of hormone-dependent activation of ER and these include interactions of the receptor with ERE half-sites alone and in combination with other DNA-bound transcription factors such as GATA1, NFkB, and specificity protein-1 (SP1). In addition, ER activates genes through protein-protein interactions with other DNAbound transcription factors such as the activator protein-1 (JUN) complex and SP proteins (Blobel & Orkin 1996 , Paech et al. 1997 , Webb et al. 1999 , Inadera et al. 2000 , Pelzer et al. 2001 , Safe 2001 , Pratt et al. 2003 , Safe & Kim 2004 , Chadwick et al. 2005 , Ghisletti et al. 2005 , Kalaitzidis & Gilmore 2005 . Several E 2 -responsive genes contain E 2 -responsive GC-rich promoters (Safe 2001 , Safe & Kim 2004 , and RNA interference studies using small inhibitory RNAs for SP1 (iSP1), SP3 (iSP3), SP4 (iSP4) or their combination (iSP) show that all three SP proteins play a role in hormonal activation of three E 2 -responsive genes, namely E2f1, Cad, and Rara (Khan et al. 2007) . Transfection with iSP was the most effective inhibitor of hormone activation of these genes. E 2 and various selective ER modulators induce or repress a broad spectrum of genes in breast cancer cells (Soulez & Parker 2001 , Inoue et al. 2002 , Levenson et al. 2002 , Lobenhofer et al. 2002 , Coser et al. 2003 , Cunliffe et al. 2003 , Frasor et al. 2003 , Scafoglio et al. 2006 ) and, in some microarray studies, E 2 decreased expression of more genes than it induced. In this study, we investigated the role of SP proteins in hormonal modulation of gene expression in MCF-7 cells by treating cells for 6 h with dimethylsulfoxide (DMSO; solvent control) or 10 nM E 2 and transfecting cells with either a nonspecific oligonucleotide (iNS) or iSP cocktail containing iSP1, iSP3, and iSP4. Using this approach, we showed that E 2 induced 67 and repressed 134 genes and 62% of these genes were SP dependent. Genes regulated by ESR1/SP could be further subdivided into three subclasses based on the effects of iSP on basal activity of these genes in which basal expression was unaffected (B 
. Interestingly, the B 0 and B C subcategories were predominant for genes induced and the B K subcategory predominated for genes repressed by E 2 -mediated activation of ESR1/SP. Our results show that the genomic ESR1/SP pathway is important for hormonal regulation of genes in MCF-7 cells.
Materials and methods
Cell culture MCF-7 cells were obtained from American Type Culture Collection (ATCC, Manassas, VA, USA) and were maintained in DMEM/nutrient mixture Ham's F12 (DMEM/F12; Sigma-Aldrich) supplemented with 2 . 2 g/l sodium bicarbonate, 5% fetal bovine serum (FBS, JRH Biosciences, Lenexa, KS, USA), and 5 ml/liter antibiotic antimycotic solution (AAS, Sigma-Aldrich). Cells were cultured and grown in a 37 8C incubator with humidified 5% CO 2 :95% air.
Reverse transcription PCR for determination of mRNA levels MCF-7 cells were cultured in serum-free DMEM/F12 for 1 day before treatment with 20 nM E 2 or 20 nM E 2 C2 mM ICI 182780. DMSO as a solvent control for 24 h or with 20 nM E 2 for 0, 2, 4, 6, 9, and 24 h. For the RNA interference studies, cells were cultured in phenol redfree DMEM/F12 supplemented with 2 . 5% charcoalstripped FBS in six-well plates until 50-70% confluent. Cells were washed once with serum-free, antibiotic-free, phenol red-free DMEM/F12. The amount of siRNA to give a maximal decrease of each target protein was determined experimentally (50 nM final concentration in the well). Lipofectamine 2000 reagent (Invitrogen) was used to transfect MCF-7 cells with siRNA (iSP1, 3, 4, or iNS) according to the manufacturer's protocol and as indicated above under RNA interference and microarray assay. The next day, cells were treated with 20 nM E 2 or DMSO as a solvent control in serum-free, antibiotic-free, phenol red-free DMEM/F12. Cells were harvested 2, 4, 6, 9, or 24 h after treatment or as indicated in the different experiments. The siRNA oligonucleotides for nonspecific small inhibitory RNA (iNS), SP1, SP3, and SP4 were obtained from Dharmacon, Lafayette, CO, USA as described above. Total RNA from the studies was isolated using the RNeasy Protect Mini Kit (Qiagen) according to the manufacturer's protocol. RNA concentration was measured by u.v. 260:280 nm absorption ratio; 1 mg RNA was reverse transcribed using Superscript II reverse transcriptase (Invitrogen) according to the manufacturer's protocol. The genes of interest were amplified from the generated cDNA by PCR cycles using Taq polymerase (Invitrogen). The PCR conditions were as follows: initial denaturation at 94 8C (2 min) followed by 29 cycles (E2F1 and KLK6), 30 cycles (VEGFA), 28 cycles (HMGB1), or 27 cycles (GAPDH) of denaturation for 30 s at 94 8C; annealing for 30 s at 54 8C; extension at 72 8C for 1 min; and a final extension step at 72 8C for 10 min. The mRNA levels were normalized using Gapdh as an internal housekeeping gene. PCR products were electrophoresed on 1 . 5% agarose gels containing ethidium bromide and visualized under u.v. transillumination, then quantitated using Image-J software. Primers obtained from IDT (Coralville, IA, USA) and used for amplification were E2F1 (sense, 5 0 -CGC ATC TAT GAC ATC ACC AAC G-3 0 ; antisense, 5 0 -GAA AGT TCT CCG AAG AGT CCA CG-3 0 ); VEGFA (sense, 5 0 -CCA TGA ACT TTC TGC TGT CTT-3 0 ; antisense, 5 0 -ATC GCA TCA GGG GCA CAC AG-3 0 ); HMGB1 (sense, 5 0 -AAC ATG GGC AAA GGA GAT CC-3 0 ); antisense, 5 0 -TAC CAG GCA AGG TTA GTG GC-3 0 ); KLK6 (sense, 5 0 -TAC CAA GCT GCC CTC TAC AC-3 0 ; antisense, 5 0 -ACA AGG CCT CGG AGG TGG TC-3 0 ); GAPDH (sense, 5 0 -AAT CCC ATC ACC ATC TTC CA-3 0 ; antisense, 5 0 -GTC ATC ATA TTT GGC AGG TT-3 0 ).
RNA interference and microarray assay
MCF-7 cells (5!10 4 ) were cultured in phenol red-free DMEM/F12 supplemented with 2 . 5% charcoal-stripped FBS without AAS in 12-well plates overnight. Cells were transfected with nonspecific siRNA (iNS) or the combination of iSP1/iSP3/iSP4 (iSP) by Lipofectamine 2000 reagent (Invitrogen), according to the manufacturer's protocol. After 6 h, the transfection medium was changed with fresh DMEM/F12 and 2 . 5% serum without phenol red. Forty-eight hours after transfection, cells were treated with (DMSO, solvent) or 10 nM E 2 (98%, Sigma-Aldrich) for 6 h. Three replicate determinations were obtained for each treatment group. Total RNA was isolated using the RNeasy Protection Mini Kit (Qiagen) according to the manufacturer's protocol. The siRNA duplexes used in this study are indicated as follows. Silencer Negative Control #1 siRNA purchased from Ambion (Austin, TX, USA) was used as iNS. The siRNA oligonucleotides for SP1, SP3, and SP4 were obtained from Dharmacon as follows: SP1, 5 0 -AUC ACU CCA UGG AUG AAA UGA dTdT-3 0 ; SP3, 5 0 -GCG GCA GGU GGA GCC UUC ACU dTdT-3 0 ; and SP4, 5 0 -GCA GUG ACA CAU UAG UGA GCdT dT-3 0 .
Microarray hybridization and data analysis
Microarray studies were carried out with the three samples obtained for each treatment group using the CodeLink Whole Genome Bioarrays (#300026) with over 50 000 probe targets per slide and, after treatment with 10 nM E 2 for 6 h, RNA was isolated for reverse transcription PCR. The microarray data for each sample were imported into GeneSpring BX7 software (Silicon Genetics, Redwood City, CA, USA) for data analysis. The data were normalized in two steps. First, for each array, the expression value of each gene was divided by the median of the expression values in that array. Second, for each gene, the expression value in each array was divided by the median expression value of that gene across all of the arrays. Genes that were flagged 'L' by the CodeLink preprocessing software, i.e. with low signal to background noise ratio, were excluded from the subsequent statistical analysis. One-way parametric ANOVA test was performed to detect significant changes of gene expression. Benjamini-Hochberg false discovery rate as multiple testing correction and Tukey post hoc test were applied. The false discovery rate cut-off was set to 0 . 05 due to the large number of genes on the chip and the small number of microarrays used in the experiment. 
Results
Previous microarray studies have investigated hormonal modulation of genes in breast cancer cells under various conditions and there is evidence that genes, with different and overlapping functions, are induced and repressed (Soulez & Parker 2001 , Inoue et al. 2002 , Levenson et al. 2002 , Lobenhofer et al. 2002 , Coser et al. 2003 , Cunliffe et al. 2003 , Frasor et al. 2003 , Scafoglio et al. 2006 , Jonsson et al. 2007 . Several reports show that E 2 induces and represses genes that are activated through a nonclassical ESR1/SP mechanism in which ESR1 binds SP proteins but not promoter DNA (Safe 2001 , Safe & Kim 2004 ; however, the contributions of this pathway to hormonal activation of genes is not well defined. In this study, MCF-7 cells were treated with DMSO (solvent) or 10 nM E 2 for 6 h and transfected with a nonspecific oligonucleotide (iNS) or a combined cocktail (iSP) of small inhibitory RNAs for SP1 (iSP1), SP3 (iSP3), and SP4 (iSP4), which has previously been used to simultaneously knockdown all three SP proteins (Khan et al. 2007) . Western blot analysis of whole-cell lysates from cells transfected with INS or iSP confirms efficient knockdown of all three SP proteins (Fig. 1A) . Results in Fig. 1B show that in cells transfected with iNS and treated with DMSO or E 2 , there were 67 and 134 genes significantly (P!0 . 01) induced and repressed respectively, and this was consistent with other studies in MCF-7 cells showing that E 2 primarily decreases gene expression (Frasor et al. 2003 (Frasor et al. , 2004 . It is important to point out that our selection of significantly expressed genes is based on a stringent condition (P!0 . 01) that reflects the large number of probes on the slides and the small number of samples. Selection of these stringent conditions is consistent with a report by Hu and coworkers (Hu et al. 2005) , which uses the false discovery rate to estimate the number of required samples per condition for achieving a desired level of significance. This has to be taken into account when comparing the results of our statistical analysis with the already published similar studies. For example, Frasor and coworkers (Frasor et al. 2003) identified over 400 genes with 'robust level of regulation,' but the microarrays used in their experiment contained w12 000 genes and the decision to place a gene in the reported list was based on a different scoring procedure.
After transfection of cells with iSP, hormoneregulated genes in MCF-7 cells can be subdivided into four major categories (Fig. 1C) . Categories A and B represent SP-dependent genes induced or repressed by E 2 (Tables 1 and 2 ) and categories C and D represent SP-independent genes induced or repressed by E 2 respectively (Tables 3 and 4) . A fifth category, F, represents a substantial number of genes (85) that are not affected by treatment with E 2 ; however, after SP protein knockdown (Fig. 1A) , category F genes are either induced or repressed by E 2 (Table 5) . SP proteins are overexpressed in breast tumor compared with nontumor cells (Mertens-Talcott et al. 2007) , and it is possible that as SP proteins increase during mammary carcinogenesis, category F genes become hormone insensitive. The decision to assign a gene to one of the five categories was based on two cut-off points; genes with fold change of 0 . 8 or less were considered repressed while the genes with fold change of 1 . 3 or greater were considered induced. The selection of these thresholds was based on the observation that varying them by as much as 0 . 02 produced small changes in the categories; only one to five genes would change their category membership.
Category A genes were induced by E 2 and induction of these genes was inhibited after cotransfection with small inhibitory RNAs for SP1, SP3, and SP4 (combined; iSP). Table 1 summarizes one subset of genes induced by E 2 (1 . 3-to 2 . 4-fold) in which transfection with iSP significantly decreased fold induction, whereas basal activity was minimally affected by iSP since the ratio of the DMSO values in the iSP and iNS treated groups (iSPD/iNSD) varied only from 0 . 81 to 1 . 77 and were considered to be unchanged. These were classified as
)-inducible genes. A second subset of genes was also induced by E 2 (1 . 30-to 4 . 38-fold), but the iSPD/iNSD ratios varied from 1 . 35 to 3 . 9, suggesting that basal activities of these hormoneinducible genes were repressed by SP proteins. These genes were classified as
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The role of SP proteins in mediating hormonal regulation of select genes was also confirmed by realtime PCR, and the four genes selected include E2f1, Vegfa, Hmg, and Klk6. Although VEGFA was not detected in the microarray studies due to the stringent conditions, we included VEGFA since ongoing studies show consistent downregulation of this gene by E 2 in MCF-7 cells (data not shown). Figure 3 illustrates the time course induction or repression of these genes after treatment with 20 nM E 2 for 2, 4, 6, 9, and 24 h. Significant effects were observed within 2 h and persisted for up to 24 h. We used a higher concentration of E 2 (20 nM) for the RT-PCR experiments and this was based on preliminary studies showing a maximal response observed using 20 nM E 2 . The role of iSP in mediating hormone-dependent activation of these genes was determined in MCF-7 cells (Fig. 4) and the results were similar to those observed in the microarray experiments. Moreover, we also observed that the antiestrogen ICI 182780 (fulvestrant) also significantly inhibited the E 2 -induced or -repressed genes. These results demonstrate that E2 induces and represses a diverse spectrum of genes in MCF-7 cells as previously reported (Soulez & Parker 2001 , Inoue et al. 2002 , Levenson et al. 2002 , Lobenhofer et al. 2002 , Coser et al. 2003 , Cunliffe et al. 2003 , Frasor et al. 2003 , Scafoglio et al. 2006 , Jonsson et al. 2007 , and this study shows that O60% of these genes are dependent on SP proteins.
Discussion
Gene expression profiling has been extensively used to understand global changes in gene expression in various endogenous biochemical processes and during development of various diseases including breast cancer (Sorlie et al. 2003 , Andersson et al. 2005 . The patterns of gene expression in different tumor types have been extensively investigated and are used for disease prognosis and for predicting responses to various chemotherapies. For example, gene expression profiling has been used for diagnosis, prognosis, and treatment of breast cancer metastasis and for recommending adjuvant chemotherapy for breast cancer (Driouch et al. 2007 , Henry & Hayes 2007 . Gene expression profiles in breast cancer cells have been extensively investigated in several different (Soulez & Parker 2001 , Inoue et al. 2002 , Levenson et al. 2002 , Lobenhofer et al. 2002 , Coser et al. 2003 , Cunliffe et al. 2003 , Frasor et al. 2003 , Scafoglio et al. 2006 , Jonsson et al. 2007 . Results of these studies demonstrate that hormone-activated genes and gene networks are highly complex and variable and demonstrate the broad effects of E 2 on gene expression. For example, Frasor et al. (2003) showed that E 2 regulated over 400 genes in 12 different functional categories in MCF-7 cells and the majority (76%) of these genes were downregulated by E 2 . Similar results were observed in this study (Fig. 1B and C) .
Frasor et al. also demonstrated distinct temporal differences in the expression of some E 2 -induced and repressed genes (Frasor et al. 2003 (Frasor et al. , 2004 .
Several studies show that SP proteins play a pivotal role in hormone-dependent induction of genes (Safe 2001 , Safe & Kim 2004 , and recent reports have shown that these transcription factors are also involved in gene repression (Higgins et al. 2006 , Stossi et al. 2006 . Recent studies on genome-wide interactions of ESR1 with DNA demonstrate that many ESR1-binding sites for specific genes are distal from their corresponding transcription start sites (Carroll & Brown 2006 , Lin et al. 2007 , whereas most promoter studies have focused on proximal E 2 -responsive promoter sites. Thus, the E 2 -responsive proximal GC-sites identified in previous studies (Safe & Kim 2005) may also contain functional E 2 -responsive distal sites and further analysis of the potentially ESR1/SPdependent genes listed in Tables 1 and 2 will have to examine both proximal and distal cis-elements. For example, based on proximal promoter analysis, we previously identified retinoic acid receptor a1 (RARA) as an E 2 -responsive gene regulated by ESR1/SP (Sun et al. 1998 regulation of some ESR1-dependent genes using a whole-genome cartography approach for identifying ESR1-binding sites (Lin et al. 2007) .
Most of the previous research have focused on SP1 protein; however, studies in this laboratory have now shown that SP1, SP3, and SP4 proteins are overexpressed in breast cancer cells (Mertens-Talcott et al. 2007) and simultaneous knockdown of one or all three SP proteins block E 2 -dependent expression of the Rara, E2f, and Cad genes (Khan et al. 2007) . These genes are primarily activated through ESR1/SP binding to GC-rich promoter sites (ER:DNA independent). In this study, we have selected a single concentration (10 nM) of E 2 and one time point (6 hr) to investigate the role of SP proteins in mediating hormonal activation of genes in MCF-7 cells. This approach was not designed to identify all hormonally regulated genes but to investigate the importance of SP proteins in this induction response. Results of this study demonstrate that in MCF-7 cells treated with E 2 , 67 genes are induced and 134 genes are repressed (Fig. 1B) , and this ratio of induced/repressed hormone-responsive genes is similar to the results of previous studies (Frasor et al. 2003) . However, the use of RNA interference shows that out of these 201 genes, over 60% of the genes affected by E 2 are also dependent on SP proteins (categories A and B). We also observed that within the four categories of genes (Tables 1-4 , we observed that among the 201 genes induced or repressed by E 2 , the basal activity of 57 genes was unaffected after transfection with iSP, whereas the basal activity of 144 genes was either decreased (110 genes; B K ) or increased (34 genes; B C ) (Fig. 3) . Since SP proteins are important for constitutive expression of multiple mammalian and viral genes, it is not surprising that loss of SP1, SP3, and SP4 resulted in decreased basal expression of 110 out of 144 of those genes affected by iSP. However, SP protein knockdown also enhanced basal activity of 34 genes and this may be due to the SP3 protein that can act as both an enhancer and a suppressor of gene expression (Black et al. 2001 , Suske et al. 2005 . It should also be noted that knockdown of SP1, SP3, and SP4 proteins will not only affect ESR1/ SP-regulated genes but may also result in altered expression of ESR1, coactivators, and other nuclear cofactors required for gene induction or expression. We are currently investigating the molecular mechanisms associated with the E 2 -dependent induction and repression of individual SP-dependent genes listed in Tables 1  and 2 . These studies will determine the role of SP proteins and identify both proximal and distal GC-rich sites that are functional cis-elements in ESR1/SP action.
Analysis of the effects of SP knockdown on hormoneresponsive gene expression revealed a fifth category (F) of genes (Fig. 1C ) that were not induced or repressed by E 2 in MCF-7 cells transfected with iNS. There were 85 E 2 -nonresponsive genes in category F; however, after transfection of iSP, treatment with E 2 induced or repressed expression of these genes that were further subdivided into B 0 , B C , and B K subcategories. Category F genes were further subdivided into multiple (112) biological processes and only 30 of these were in common with biological processes associated with genes in categories A-D. It has been reported that SP proteins are overexpressed in multiple tumor types (Zannetti et al. 2000 , Shi et al. 2001 , Chiefari et al. 2002 , Wang et al. 2003 , Hosoi et al. 2004 , Yao et al. 2004 , Mertens-Talcott et al. 2007 , and our recent studies have shown that SP proteins are highly expressed in breast cancer cells but barely detectable in non-transformed mammary cells (Mertens--Talcott et al. 2007) . Lou and coworkers also showed that malignant transformation of human fibroblast cells results in an 8-to 18-fold increase in the expression of SP1 in the tumor cells compared with the parental cells (Lou et al. 2005) . These studies suggest that overexpression of SP proteins contributes to tumor formation; thus, genes in category F, which regain hormone responsiveness in MCF-7 cells transfected with iSP, may play an endogenous role in normal or precancerous Figure 4 Effects of (A) RNA interference or (B) ICI 182780 on E 2 -dependent induction or repression of genes. MCF-7 cells were transfected with iNS or iSP and treated with DMSO or 20 nM E 2 or treated with DMSO, E 2 alone, or E 2 plus 2 mM ICI 182780, and gene expression was determined by real-time PCR as described in the Materials and methods. Results are meansGS.E.M. for three mammary cells where SP protein levels are relatively low. Their hormone responsiveness is subsequently silenced with increased expression of SP proteins found in MCF-7 and other breast cancer cell lines. Current studies are examining a variety of tumorigenic and non-tumorigenic mammary cells to further investigate the functions and changes in expression of category F genes and the role of SP proteins in mediating gene silencing.
In summary, results of these microarray studies confirm that in MCF-7 cells, E 2 predominantly inhibits expression of genes. By combining the microarray data with simultaneous knockdown of SP1, SP3, and SP4 proteins, we have demonstrated that these transcription factors are critical regulators of hormone-dependent gene induction and repression. Moreover, the latter response has recently been confirmed in two studies on SP-dependent downregulation of KDR and cyclin G2 in MCF-7 cells treated with E 2 (Stossi et al. 2006 , Higgins et al. 2008 . Previous studies show that VEGFA and KDR are induced by E 2 in ZR-75 cells (Stoner et al. 2004 , Higgins et al. 2006 , whereas in MCF-7 cells, E 2 decreases expression of both genes (Higgins et al. 2008; Figs 3 and 4) . This unusual cell context-dependent difference in hormonal regulation of VEGFA/KDR in two ER-positive breast cancer cells lines may be due to altered expression of critical cofactors and this is currently being investigated. It should also be noted that ESR1 is constitutively associated with proximal E 2 -responsive GC-rich sequences and these interactions are not enhanced by E 2 in a ChIP assay (Higgins et al. 2006 , 2008 , Khan et al. 2007 . We are now examining coactivators as potential markers of ESR1/SP-mediated transactivation. Thus, in MCF-7 cells treated with E 2 for 6 h, most hormonally regulated genes were SP dependent and, for the 76 genes in categories C and D where iSP did not affect hormone inducibility, loss of SP affected basal expression of 53 out of these 76 genes. Thus, among the 201 genes in categories A-D, loss of SP proteins affected hormone-induced or basal expression of over 88% (178/201) of all genes. It was also apparent that hormone-mediated responses such as increased cell proliferation involves mobilization genes that regulate a large number of functional processes (Tables 1-4) , and current studies are focused on interconnections between pathways that lead to E 2 -induced proliferation and survival pathways in MCF-7 cells.
Declaration of interest

